| 28 Aug, 02:41 pm | — | … | SOLARA: Solara Active Pharma Sciences Limited has informed the Exchange regarding Intimation in connection with the receipt of Rectification Order. | nse |
| 25 Aug, 06:34 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange about Business Responsibility and Sustainability Report for the financial year 2025-26. | nse |
| 25 Aug, 06:27 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Reg. 34 (1) Annual Report. | bse |
| 19 Aug, 11:11 am | — | … | Solara Active Pharma Sciences Limited has informed the Exchange regarding Conversion of partly paid-up Rights Equity Shares into fully paid-up equity shares in Conversion of partly paid-up Rights Equity Shares into fully paid-up equity shares in relation to the rights issue by the Company, upon receipt of the Call Monies, as applicable. | nse |
| 07 Aug, 03:51 pm | — | … | SOLARA: Solara Active Pharma Sciences Limited has informed the exchange regarding the update with respect to our intimation dated July 23, 2026, regarding appointment of Chief Information Officer ("CIO") and Senior Management Personnel ("SMP") | nse |
| 29 Jul, 11:35 am | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 29 Jul, 11:34 am | — | … | Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of Earnings conference call pertaining to financial results of the Company for the quarter ended June 30, 2026 | nse |
| 24 Jul, 04:36 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange about Copy of Newspaper Publication providing extract of the unaudited financial results (Standalone and Consolidated) for the quarter ended June 30, 2026 | nse |
| 24 Jul, 02:12 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange regarding Submission of Machine Readable copy of financial results for the quarter ended June 30, 2026. | nse |
| 23 Jul, 07:17 pm | — | … | Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q1 FY27 Earnings Call held on July 23, 2026 at 16.00 IST | nse |
| 23 Jul, 07:16 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 23 Jul, 05:27 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | bse |
| 23 Jul, 05:27 pm | — | … | Monitoring Agency Report for the quarter ended June 30, 2026 | nse |
| 23 Jul, 04:41 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 | nse |
| 23 Jul, 04:40 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended June 30, 2026. | bse |
| 23 Jul, 01:52 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange regarding the appointment of Mr. Ajit Manocha as Chief Information Officer (CIO) and designated him as Senior Management Personnel (SMP) with effect from August 10, 2026. | nse |
| 23 Jul, 01:36 pm | — | … | Solara Active Pharma Sciences Limited has informed the exchange regarding the Press release dated July 23, 2026 titled - Solara reports Strong Q1 27 Base business performance with continued Growth and Profitability | nse |
| 23 Jul, 01:34 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 23 Jul, 01:30 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 23 Jul, 01:23 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Unaudited Financial Results For The Quarter Ended June 30, 2026 | bse |
| 23 Jul, 01:17 pm | — | … | Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia, to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report for the said period. | nse |
| 16 Jul, 08:26 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Thursday, July 23, 2026 at 4.00 PM IST to discuss the Company's unaudited financial results for the quarter ended June 30, 2026. | nse |
| 16 Jul, 07:59 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 ('Listing Regulations') | bse |
| 03 Jul, 05:28 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange about approval of Reminder-cum-Forfeiture Notice by the Rights Issue Committee members, to be issued to the partly paid shareholders | nse |
| 26 Jun, 06:14 pm | — | … | SOLARA: Copy of newspaper advertisement regarding the dispatch of notices to shareholders for the transfer of equity shares to the IEPF in respect of the unclaimed and unpaid dividend for the financial year 2018 19. | nse |
| 26 Jun, 06:04 pm | — | … | SOLARA: Dispatch of notices regarding the transfer of equity shares to the IEPF in respect of the unclaimed and unpaid dividend for the financial year 2018 19. | nse |
| 26 Jun, 05:56 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Transfer Of Equity Shares Of The Company To The IEPF | bse |
| 23 Jun, 06:31 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Credit Rating | bse |
| 23 Jun, 06:28 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange about Credit Rating | nse |
| 10 Jun, 02:48 pm | procedural | 0 | Solara Active Pharma Sciences Ltd clarified the company’s volume movement in response to an email received from BSE on June 10, 2026. | bse |
| 10 Jun, 12:56 pm | procedural | 0 | BSE sought clarification from Solara Active Pharma Sciences Ltd on 10 Jun 2026 regarding movement in volume; reply is awaited. | bse |
| 10 Jun, 10:26 am | procedural | 0 | NSE noted a significant increase in Solara Active Pharma Sciences’ trading volume, sought an explanation, and received the company’s response. | nse |
| 09 Jun, 06:19 pm | procedural | 0 | NSE observed a significant volume increase in Solara Active Pharma Sciences and wrote to the company seeking clarification; company response is awaited. | nse |
| 05 Jun, 07:03 pm | — | … | SOLARA: Solara Active Pharma Sciences Limited has informed the exchange regarding the Special window for Transfer and Dematerialisation of shares | nse |
| 29 May, 12:31 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 27 May, 01:17 pm | — | … | Pronomz Ventures LLP has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 | nse |
| 21 May, 12:21 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings conference call pertaining to financial results of the Company for the quarter and year ended March 31, 2026. | nse |
| 21 May, 12:12 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 16 May, 05:20 pm | — | … | Copy of newspaper publication in relation to the financial results for the quarter and year ended March 31, 2026 | nse |
| 15 May, 05:28 pm | — | … | Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q4 FY26 Earnings Call held on May 15, 2026 at 15.00 IST. | nse |
| 15 May, 05:25 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 15 May, 05:19 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | bse |
| 15 May, 05:17 pm | — | … | Monitoring Agency Report for the quarter ended March 31, 2026 | nse |
| 15 May, 02:48 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Intimation Regarding The Adoption Or Amendments Of Policies | bse |
| 15 May, 02:47 pm | — | … | Solara Active Pharma Sciences Limited has informed the exchange regarding the approval and adoption of Board Evaluation policy and amendment to Whistle Blower Policy. | nse |
| 15 May, 02:44 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 | nse |
| 15 May, 02:42 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended March 31, 2026. | bse |
| 15 May, 02:27 pm | — | … | Solara Active Pharma Sciences Limited has informed the exchange regarding the reappointment of Internal Auditor and Cost Auditor for the FY 2026-27. | nse |
| 15 May, 02:11 pm | — | … | Conversion Of Partly Paid Up Rights Equity Shares into Fully Paid Up Equity Shares in Relation to The Rights Issue by the Company, upon receipt of the Second and Final Call Monies | nse |
| 15 May, 01:25 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |